4Moving Biotech Closes Euros 12M Financing for Knee OA Program
4Moving Biotech (4MB), a clinical-stage biotechnology company and a spin-off of 4P-Pharma, developing a first-in-class disease-modifying osteoarthritis drug (DMOAD) for knee osteoarthritis, announced on February 10th the closing of a €12 million financing, completed through a structured and coordinated funding process. This financing was secured from a pool of private investors and family offices, who […]
GC Aesthetics Announces Multi-Center Clinical Study to Evaluate PERLE Breast Implant
GC Aesthetics (GCA), a privately-held medical technology company providing aesthetic and reconstruction solutions for global healthcare markets, announced the initiation of a significant multi-center and prospective clinical study in Europe to evaluate, and confirm, the safety, effectiveness, and patient satisfaction associated with the innovative PERLE smooth opaque round breast implant. This extensive study brings together […]
